All lobbying filings

AVENUE SOLUTIONS

Lobbying for EDWARDS LIFESCIENCES LLC · Patient-focused innovations for structural heart disease and critical care monitoring

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Lobbying activity 1

Medicare/Medicaid

Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.